Mitigation of photodamage in analytical reactions
Compositions, devices, systems and methods for reducing and/or preventing photodamage of one or more reactants in illuminated analytical reactions by one or more of incorporating photodamage mitigating agents within the reaction mixture and/or interrogating different observation regions of the reaction mixture for a period that is less than a photodamage threshold period.
1. A method of performing an illuminated reaction, comprising: providing a substrate having an observation region and a reaction mixture disposed thereon, wherein the reaction mixture comprises
a) a single molecule of a polymerase confined within the observation region,
b) a plurality of second reactants comprising substrates for the polymerase, each of which comprises a fluorescent label,
c) and photodamage mitigating agents which are present in a concentration sufficient to reduce photodamage to the polymerase comprising more than one different triplet state quencher wherein the photodamage mitigating agents reduce an amount of photodamage to the polymerase during the interaction between the single molecule of the polymerase with one of the second reactants under excitation illumination of the second reactants that would occur in the absence of the photodamage mitigating agents; and
illuminating the reaction mixture on the substrate having an observation region with the excitation illumination of the second reactants.
2. The method of claim 1 , further comprising the step of monitoring the reaction between the polymerase and the one of the second reactants while illuminating the reaction mixture.
3. The method of claim 1 , wherein the polymerase is present in a limited concentration within the reaction mixture, wherein the limited concentration is selected from the group consisting of less than 200 nM, less than 10 nM, and less than 10 pM.
4. The method of claim 1 , wherein one of the more than one different triplet state quencher is selected from the group consisting of ascorbic acid, mercaptoethylamine, n-propyl gallate, p-phenylenediamine, hydroquinone, sodium azide, diazobicyclooetane and dithiothreitol.
5. The method of claim 1 , wherein the photodamage mitigating agents further comprise a singlet oxygen scavenger or singlet oxygen quencher.
6. The method of claim 5 , wherein the singlet oxygen scavenger or singlet oxygen quencher comprises at least a first agent selected from the group consisting of superoxide dismutase, glucose oxidase/catalase, glutathione peroxidase, ergothionine, methionine, cysteine, beta-dimethyl cysteine, mercaptopropionylglycine, 2-mercaptoethane sulfonate sodium, glutathione, dithiothreitol, N-acetyl cysteine, captopril, lycopene, gamma-carotene, astazanthin, canthazanthin, alpha-carotene, beta-carotene, bixin, zeaxanthin, lutein, bilirubin, biliverdin, tocopherol, polyene dialdehydes, melatonin, alpha-tocopheryl succinate, pyridoxinel, hydrazine, sodium sulfite and hydroxylamine.
7. The method of claim 1 , wherein the photodamage mitigating agents comprise dithiothreitol and mercaptoethylamine.
8. The method of claim 1 , wherein the more than one different photodamage mitigating agents which are different triplet state quenchers comprise dithiothreitol and mercaptoethylamine.
9. The method of claim 1 , wherein the polymerase is a DNA polymerase.
10. A method of performing an enzyme reaction, comprising:
providing a single polymerase within an observation region;
contacting the single polymerase with a reaction mixture comprising a fluorescent or fluorogenic substrate for the polymerase under an excitation illumination for the fluorescent or fluorogenic substrate, in the presence of photodamage mitigating agents which are present in a concentration sufficient to reduce photodamage to the polymerase, and further wherein the photodamage mitigating agents comprise at least one triplet state quencher selected from the group consisting of ascorbic acid, dithiothreitol, mercaptoethylamine, beta-mercaptoethanol, n-propyl gallate, p-phenylenediamine, hydroquinone, sodium azide and diazobicyclooctane and at least one singlet oxygen scavenger or singlet oxygen quencher selected from the group consisting of superoxide dismutase, glucose oxidase/catalase, glutathione peroxidase, ergothionine, methionine, cysteine, beta-dimethyl cysteine, mercaptopropionylglycine, 2-mercaptoethane sulfonate sodium, glutathione, N-acetyl cysteine, captopril, lycopene, gamma-carotene, astazanthin, canthazanthin, alpha-carotene, beta-carotene, bixin, zeaxanthin, lutein, bilirubin, biliverdin, tocopherol, polyene dialdehydes, melatonin, alpha-tocopheryl succinate, pyridoxinel, hydrazine, sodium sulfite and hydroxylamine, and further wherein only a portion of the reaction mixture within the observation region is exposed to the excitation illumination.
11. The method of claim 10 , wherein the single polymerase is immobilized within the observation region.
12. The method of claim 11 , wherein the observation region is within an optical confinement.
13. The method of claim 12 , wherein the optical confinement comprises a zero mode waveguide.
14. The method of claim 1 , wherein the photodamage mitigating agents further comprise a glucose-oxidase/catalase enzyme system.
15. The method of claim 10 , wherein the polymerase is a DNA polymerase.
16. A method of monitoring a base extension reaction, comprising:
providing a single polymerase within an observation region;
contacting the single polymerase with a reaction mixture comprising at least a first fluorescent or fluorogenic nucleotide analog under an excitation illumination for the fluorescent or fluorogenic nucleotide analog in the presence of more than one different photodamage mitigating agent, which are present in a concentration sufficient to reduce photodamage to the polymerase, and further wherein the fluorescent or fluorogenic nucleotide analog is a phosphate labeled nucleoside polyphosphate; and
monitoring a fluorescent signal emitted from the observation region in response to illumination with the excitation radiation of the fluorescent or fluorogenic nucleotide analog, wherein the excitation radiation does not excite a subset of additional fluorescent or fluorogenic nucleotide analogs that are within the reaction mixture but outside of the observation region.
17. The method of claim 16 , wherein one of the more than one different photodamage mitigating agent is selected from the group consisting of ascorbic acid, dithiothreitol, mercaptoethylamine, beta-mercaptoethanol, n-propyl gallate, p-phenylenediamine, hydroquinone, sodium azide, diazobicyclooctane, superoxide dismutase, glucose oxidase/catalase, glutathione peroxidase, ergothionine, methionine, cysteine, beta-dimethyl cysteine, mercaptopropionylglycine, 2-mercaptoethane sulfonate sodium, glutathione, N-acetyl cysteine, captopril, lycopene, gamma-carotene, astazanthin, canthazanthin, alpha-carotene, beta-carotene, bixin, zeaxanthin, lutein, bilirubin, biliverdin, tocopherol, polyene dialdehydes, melatonin, alpha-tocopheryl succinate, pyridoxinel, hydrazine, sodium sulfite and hydroxylamine.
18. The method of claim 16 , wherein the observation region comprises an optical confinement.
19. The method of claim 18 , wherein the optical confinement comprises a zero mode waveguide.
20. The method of claim 16 , wherein the phosphate labeled nucleoside polyphosphate is a phosphate labeled nucleoside tetraphosphate.
21. The method of claim 16 , wherein the polymerase is a DNA polymerase.